ArticleScientific reports2022

Co-treatment with Esculin and erythropoietin protects against renal ischemia-reperfusion injury via P2X7 receptor inhibition and PI3K/Akt activation.

Walaa H El-Maadawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.